The Downstream Column Podcast

The Downstream Column Podcast

Latest Episodes

Addressing the increasing demand for single-use technologies and supply chain shortages with future proof systems
October 28, 2021

Phil Sanders talks about the increase in demand for single-use equipment and consumables and how this has led to supply chain shortages.

Evolving Beyond the Status Quo with Next Generation Buffer Prep Solutions
August 17, 2021

In this podcast, we spoke with Chris Rombach, Vice President of Sales and Marketing at Asahi Kasei Bioprocess America about buffer prep and delivery systems. We discussed current pain points and how n

Integrated Freezing Solutions to Minimize Risk and Preserve Product Quality
April 27, 2021

Claire Jarmey-Swan, Global Product Manager, Pall Corporation talks about the evolution freeze thaw technologies and how these new methods can streamline the process, minimize loss and maintain the highest product quality.

Resolving Large Scale Buffer Management Challenges
November 29, 2017

In this podcast, we interviewed Joakim Lundvist, Modality Manager, BioProcess™ Hardware, GE Healthcare about large-scale buffer management challenges. Buffer preparation is known to be one of the most

Job Outlook for the Biomanufacturing Industry a Recruiter’s Perspective
April 05, 2017

In this podcast, we interviewed Hillary Kaplan, Director, Bioprocess CMC Development & Operations, Klein Hersh about the job outlook for the biomanufacturing industry from a recruiter’s perspective. H

Cell Culture Media Optimization – It’s about more than just high protein titer
July 19, 2016

Dr. Adam Elhofy, Ph.D., CSO, Essential Pharmaceuticals, talks about cell culture media optimization. We discussed the evolution of cell culture media optimization, current goals, and the latest strategies and tools being used.

Automated Stem Cell Based High Throughput Drug Screening for ALS and Parkinson’s
June 14, 2016

Dr. Jan Bruder talks about his work at the Max Planck Institute for Molecular Biology in Münster Germany and his group’s use of automated high throughput drug screening program for ALS and Parkinson’s Disease.